<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cerebral venous and dural sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> (CVDST) is a rare but not uncommon life-threatening disease accounting for less than 1% of <z:hpo ids='HP_0001297'>stroke</z:hpo>, affecting people of any age group, predominantly the extremes of age </plain></SENT>
<SENT sid="1" pm="."><plain>CVDST carries a variable prognosis: although the majority of cases are associated with complete recovery, outcome may be fatal in less than 10% of patients </plain></SENT>
<SENT sid="2" pm="."><plain>Thrombolysis has been widely used in CVDST in patients with rapidly deteriorating symptoms who fail to improve despite adequate anticoagulation, but the exact therapeutic time window remains unclear </plain></SENT>
<SENT sid="3" pm="."><plain>We report a case of CVDST with rapid clinical deterioration despite therapeutic anticoagulation treated with direct endovascular thrombolysis with intravenous recombinant tissue plasminogen activator 1 week after presentation with complete recovery, and we present a review of the literature on the efficacy and safety of thrombolysis in CVDST </plain></SENT>
</text></document>